A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...
Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...
The team found a notable correlation between genetics that predicted low cholesterol and a lower risk of dementia, suggesting ...
The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...
These biotech IPOs plan to move forward during shutdown © 2025 American City Business Journals. All rights reserved. Use of ...
An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage ...
People with genetic variants that naturally help them have lower cholesterol also have a lower risk of dementia. For those ...
Alector said on Tuesday its experimental drug failed to slow the progression of a rare form of dementia in a late-stage trial, prompting the company to end the study and cut nearly half its workforce.
Wilmington Star-News on MSN
From surviving cancer to battling Alzheimer’s, these athletes tackle IRONMAN 70.3 NC
A Southport cancer survivor and a Florida man fighting Alzheimer's are among inspiring athletes competing in Saturday's ...
Everyday Health on MSN
New Blood Test to Rule Out Alzheimer’s Gets FDA Clearance
The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...
In our experience, when your child dies of a drug overdose, you feel like a failure. You feel like you're responsible, and ...
The negative readout led to a collapse in share price for Alector, which now plans to cut almost half of its workforce while refocusing and finding a new R&D leader.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results